DSpace About DSpace Software
 

Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1749

Title: Symtomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource limited setting (Uganda).
Authors: Songa, Patricia Mwebaze
Castelnuovo, Barbara
Mugasha, Estella Birabwa
Ocama, Ponsiano
Kambugu, Andrew
Keywords: Antiretroviral treatment
HIV/AIDS
Resource-Limited Setting
Uganda
infectious diseases
Issue Date: 2007
Publisher: University of Chicago Press
Citation: Songa, P.M., Castelnuovo, B., Mugasha, E.B., Ocama, P., Kambugu, A. (2007). Symtomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource limited setting (Uganda). Clinical Infectious Diseases, 45
Abstract: We describe 24 Ugandan patients with human immunodeficiency virus infection who developed symptomatic hyperlactatemia associated with the use of nucleoside analogues. All patients were receiving combination therapy that contained stavudine. The median serum lactate level was 6.6 mmol/L. All patients had their antiretroviral treatment regimen discontinued. Hospital admission was required for 5 patients. Five patients died.
URI: DOI: 10.1086/520023
http://hdl.handle.net/123456789/1749
ISSN: 1058-4838
Appears in Collections:Research Articles (Health-Sciences)

Files in This Item:

File Description SizeFormat
mwebaze-chs-res.pdf72KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback